ArticleScientific reports2026
MoVe: an integrated tool to explore the relationship between human mobility and vector-borne disease.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Understanding the role of human mobility in disease transmission is crucial for effective intervention. Analyzing mobility patterns can identify routes of transmission and highlight vulnerable populations. While tools exist for mobility analysis and disease simulation, none integrates all the needed capabilities into a single platform. Such integration is essential for seamless exploration of key questions and what-if scenarios. The MoVe (Mobility analysis for Vector-borne disease) platform meets this need by combining mobility analysis with agent-based simulation. It enables exploratory data analysis, generates mobility metrics, identifies stop locations, visualizes data, and allows users to run simulations based on mobility and risk factors. To demonstrate MoVe’s effectiveness, the platform was used in a case study of malaria transmission along the Thai-Myanmar border, where importation of infection complicates elimination efforts in Thailand. The spatial analysis shows distinct mobility patterns into high-risk areas among different occupational groups. By removing different types of cross-border mobility from the simulation, we quantify the impact of Thai and Myanmar migration on malaria infection rates in Thailand. These findings highlight the tool’s potential for understanding vector-borne disease transmission dynamics and its applicability to other regions and diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.